"According to the latest report published by Data Bridge Market Research, the Targeted Cancer Drugs Market The global targeted cancer drugs market size was valued at USD 75.05 billion in 2025and is expected to reach USD 91.44 billion by 2033, at a CAGR of 2.50% during the forecast period Winning Targeted Cancer Drugs Market research report is a persuaded...

The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...